Record 1083   View: Standard Glossary  HistCite Guide
Author(s): Fuxe K; Dahlstrom A; Hoistad M; Marcellino D; Jansson A; Rivera A; Diaz-Cabiale Z; Jacobsen K; Tinner-Staines B; Hagman B; Leo G; Staines W; Guidolin D; Kehr J; Genedani S; Belluardo N; Agnati LF
Title: From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: Wiring and volume transmission
Source: BRAIN RESEARCH REVIEWS 55 (1): 17-54
Date: 2007 AUG
Document Type: Journal : Article
DOI:  
Language: English
Comment:  
Address: Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.
Univ Gothenburg, Dept Anat & Cell Biol, S-40530 Gothenburg, Sweden.
Univ Malaga, Dept Cell Biol, E-29071 Malaga, Spain.
Univ Malaga, Dept Human Physiol, E-29071 Malaga, Spain.
Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
Univ Modena, Dept Biomed Sci, I-41100 Modena, Italy.
Univ Padua, Dept Human Anat & Physiol, Padua, Italy.
Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.
Univ Palermo, Dept Human Physiol, Palermo, Italy.
Reprint: Fuxe, K, Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.
E-mail: Kjell.Fuxe@ki.se
Abstract: After Golgi-Cajal mapped neural circuits, the discovery and mapping of the central monoamine neurons opened up for a new understanding of interneuronal communication by indicating that another form of communication exists. For instance, it was found that dopamine may be released as a prolactin inhibitory factor from the median eminence, indicating an alternative mode of dopamine communication in the brain. Subsequently, the analysis of the locus coeruleus noradrenaline neurons demonstrated a novel type of lower brainstem neuron that monosynaptically and globally innervated the entire CNS. Furthermore, the ascending raphe serotonin neuron systems were found to globally innervate the forebrain with few synapses, and where deficits in serotonergic function appeared to play a major role in depression. We propose that serotonin reuptake inhibitors may produce antidepressant effects through increasing serotonergic neurotrophism in serotonin nerve cells and their targets by transactivation of receptor tyrosine kinases (RTK), involving direct or indirect receptor/RTK interactions. Early chemical neuroanatomical work on the monoamine neurons, involving primitive nervous systems and analysis of peptide neurons, indicated the existence of alternative modes of communication apart from synaptic transmission. In 1986, Agnati and Fuxe introduced the theory of two main types of intercellular communication in the brain: wiring and volume transmission (WT and VT). Synchronization of phasic activity in the morroamine cell clusters through electrotonic coupling and synaptic transmission (WT) enables optimal VT of morroamines in the target regions. Experimental work suggests an integration of WT and VT signals via receptor-receptor interactions, and a new theory of receptor-connexin interactions in electrical and mixed synapses is introduced. Consequently, a new model of brain function must be built, in which communication includes both WT and VT and receptor-receptor interactions in the integration of signals. This will lead to the unified execution of information handling and trophism for optimal brain function and survival. (c) 2007 Elsevier B.V. All rights reserved.
Cited References:
AGHAJANIAN GK, 1974, BRAIN RES, V81, P364
AGNATI LE, 2000, PROG BRAIN RES, V125, P303
AGNATI LF, 1979, J NEUROSCI METH, V1, P365
AGNATI LF, 1980, MED BIOL, V58, P182
AGNATI LF, 1982, MED BIOL, V60, P183
AGNATI LF, 1983, NEUROSCI LETT, V35, P179
AGNATI LF, 1986, ACTA PHYSIOL SCAND, V128, P201
AGNATI LF, 1986, PROG BRAIN RES, V68, P291
AGNATI LF, 1991, CLIN J PAIN, V7, PS23
AGNATI LF, 1992, AM SCI, V80, P362
AGNATI LF, 1993, ANAESTH PHARM REV, V2, P101
AGNATI LF, 1994, NEUROREPORT, V6, P9
AGNATI LF, 1995, BRAIN RES, V676, P10
AGNATI LF, 1996, MOL MECH NEURONAL CO, P251
AGNATI LF, 2000, PROG BRAIN RES, V125, P3
AGNATI LF, 2000, VOLUME TRANSMISSION
AGNATI LF, 2003, J NEURAL TRANSM-SUPP, P1
AGNATI LF, 2003, PHARMACOL REV, V55, P509
AGNATI LF, 2005, J MOL NEUROSCI, V26, P193
AGNATI LF, 2005, J NEURAL TRANSM, V112, P45
AGNATI LF, 2006, ACTA PHYSIOL, V187, P329
AGNATI LF, 2006, CURR PROTEIN PEPT SC, V7, P3
AGNATI LF, 2006, NEW RES CONSCIOUSNES, P65
AGNATI LF, 2007, J NEURAL TRANSM, V114, P3
AKIL H, 1978, P NATL ACAD SCI USA, V75, P5170
ALBERT PR, 1996, NEUROPSYCHOPHARMACOL, V14, P19
ALHEIM K, 1997, P NATL ACAD SCI USA, V94, P2681
ALVAREZMAUBECIN V, 2000, J NEUROSCI, V20, P4091
AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73
ANDEN NE, 1964, LIFE SCI, V3, P523
ANDEN NE, 1964, NATURE, V202, P1222
ANDEN NE, 1965, AM J ANAT, V116, P329
ANDEN NE, 1965, LIFE SCI, V4, P1275
ANDEN NE, 1966, ACTA PHARMACOL KBH, V24, P263
ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P313
ANDEN NE, 1966, EXPERIENTIA, V22, P44
ANDEN NE, 1966, EXPERIENTIA, V22, P842
ANDEN NE, 1968, BRIT J PHARMACOL, V34, P1
ANDEN NE, 1970, EUR J PHARMACOL, V11, P303
ANDEN NE, 1971, J PHARMACOL EXP THER, V179, P236
ANDERSSON K, 1981, EUR J PHARMACOL, V76, P261
ANDERSSON K, 1983, EUR J PHARMACOL, V95, P271
ANDERSSON K, 1984, NEUROSCI LETT, V45, P253
ANDERSSON K, 1985, ACTA PHYSIOL SCAND, V123, P411
ANDERSSON K, 1985, EUR J PHARMACOL, V111, P295
ANDERSSON PB, 1992, NEUROSCIENCE, V48, P169
ANDREWS ZB, 2006, EUR J NEUROSCI, V24, P32
ANTHONY DC, 1997, BRAIN 3, V120, P435
AOKI C, 1992, BRAIN RES BULL, V29, P257
AOKI C, 1992, J NEUROSCI, V12, P781
AOKI C, 1994, J NEUROSCI, V14, P5202
AOKI C, 1998, CEREB CORTEX, V8, P269
ARTIGAS F, 1996, TRENDS NEUROSCI, V19, P378
ASTONJONES G, 1981, J NEUROSCI, V1, P876
ASTONJONES G, 1981, J NEUROSCI, V1, P887
ASTONJONES G, 1991, PROG BRAIN RES, V88, P47
ASTONJONES G, 1992, NEUROSCI LETT, V140, P219
ASTONJONES G, 2005, ANNU REV NEUROSCI, V28, P403
ASTONJONES G, 2005, J COMP NEUROL, V493, P99
ASTONJONES G, 2005, SLEEP MED S1, V6, PS3
ATTWELL D, 1993, NEURON, V11, P401
AZMITIA EC, 1991, J CLIN PSYCHIAT S, V52, P4
AZMITIA EC, 1996, NEUROPSYCHOPHARMACOL, V14, P35
AZMITIA EC, 2001, BRAIN RES BULL, V56, P413
BAKER DA, 2001, MON MOL NEUR 2001 P, P289
BARINAGA M, 1993, SCIENCE, V260, P487
BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441
BAUDE A, 1998, J COMP NEUROL, V402, P181
BEAUDET A, 1978, NEUROSCIENCE, V3, P851
BEHZADI Y, 2005, NEUROIMAGE, V25, P1100
BELLIDO I, 2002, NEUROSCI LETT, V317, P101
BELLUARDO N, 1997, J COMP NEUROL, V379, P226
BENJONATHAN N, 1977, ENDOCRINOLOGY, V100, P452
BENNETT MV, 1978, NEUROSCI RES PROGRAM, V16, P1
BERGHUIS P, 2005, P NATL ACAD SCI USA, V102, P19115
BJELKE B, 1988, NEUROSCI LETT, V93, P139
BJELKE B, 1989, NEUROSCI LETT, V107, P33
BJELKE B, 1993, NEUROREPORT, V5, P265
BJELKE B, 1995, NEUROREPORT, V6, P1005
BJELKE B, 1996, J CHEM NEUROANAT, V12, P37
BLASBERG RG, 1975, J PHARMACOL EXP THER, V195, P73
BLOOM F, 1978, P NATL ACAD SCI USA, V75, P1591
BLOOM F, 1980, NEUROBIOLOGY CEREBRR
BONICA JJ, 1990, J PAIN SYMPTOM MANAG, V5, P368
BOUDIN H, 1998, J NEUROSCI, V18, P8473
BOWERS CW, 1994, TRENDS NEUROSCI, V17, P315
BRANTON WD, 1978, NATURE, V274, P70
BRIGHTMAN MW, 1965, AM J ANAT, V117, P193
BRIGHTMAN MW, 2000, CELL MOL NEUROBIOL, V20, P111
BROWNLEES J, 1993, J NEUROCHEM, V60, P793
BRUZZONE R, 2006, CELL TISSUE RES, V326, P239
BUMA P, 1988, CELL TISSUE RES, V252, P107
BUNNEMANN B, 1991, VOLUME TRANSMISSION, P131
BURBACH JPH, 1981, J BIOL CHEM, V256, P2463
BURBACH JPH, 1982, ANN CLIN BIOCHEM, V19, P269
BUTCHER L, 1970, J PHARM PHARMACOL, V22, P313
CABERLOTTO L, 1998, NEUROSCIENCE, V86, P827
CAILLE I, 1996, BRAIN RES, V730, P17
CANALES JJ, 2005, NEUROBIOL LEARN MEM, V83, P93
CANALS M, 2003, J BIOL CHEM, V278, P46741
CARLSSON A, 1962, ACTA PHYSIOL SC S196, V56, P1
CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
CARLSSON A, 1964, ACTA PHYSIOL SCAND, V60, P112
CARLSSON A, 1968, J PHARM PHARMACOL, V20, P150
CARLSSON A, 1969, BRAIN RES, V12, P456
CARLSSON A, 1969, EUR J PHARMACOL, V5, P357
CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179
CARR DB, 2000, J NEUROSCI, V20, P3864
CASTREN E, 2004, CURR OPIN PHARMACOL, V4, P58
CHADI G, 1993, NEUROSCI LETT, V160, P171
CHARNEY DS, 1998, J CLIN PSYCHIAT S14, V59, P11
CHAZAL G, 1986, J NEUROCYTOL, V15, P777
CHEN KC, 2002, J NEUROCHEM, V81, P94
CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584
CHRISTIE MJ, 1993, NEUROSCIENCE, V56, P129
CIRUELA F, 2006, J NEUROSCI, V26, P2080
COLOTTA F, 1993, SCIENCE, V261, P472
COYLE JT, 2003, NEURON, V38, P157
CUELLO AC, 1983, FED PROC, V42, P2912
DAHLSTROM A, 1964, ACTA PHYSIOL SCAND S, V232, P1
DAHLSTROM A, 1964, ACTA PHYSL SCAND, V60, P293
DAHLSTROM A, 1965, ACTA PHYSIOL SCAND S, V247, P1
DAHLSTROM A, 1965, LIFE SCI, V4, P1207
DALY J, 1973, BRAIN RES, V49, P476
DALY JW, 1974, RES COMMUN CHEM PATH, V7, P175
DANA C, 1989, J NEUROSCI, V9, P2247
DAVIS TP, 1993, CRIT REV NEUROBIOL, V7, P163
DEFELIPE J, 1992, TRENDS NEUROSCI, V15, P237
DELAMORA MP, 1997, NEUROCHEM RES, V22, P1051
DELARCO A, 2003, J NEUROCHEM, V85, P23
DELARCO A, 2007, J NEURAL TRANSM, V114, P32
DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148
DESCARRIES L, 1975, BRAIN RES, V100, P563
DESCARRIES L, 1977, BRAIN RES, V133, P197
DESCARRIES L, 1991, VOLUME TRANSMISSION, P53
DESCARRIES L, 1996, J COMP NEUROL, V375, P167
DESCARRIES L, 1998, J PHYSIOLOGY-PARIS, V92, P215
DESCARRIES L, 2000, PROG BRAIN RES, V125, P27
DEWIED D, 1982, PHYSIOL REV, V62, P976
DIAZ J, 1995, NEUROSCIENCE, V65, P731
DJAMGOZ MBA, 1992, NEUROCHEM INT, V20, P139
DOURNAUD P, 1998, J NEUROSCI, V18, P1056
DSA C, 2002, BIPOLAR DISORD, V4, P183
DUGGAN AW, 1990, NEUROSCIENCE, V35, P195
DUGGAN AW, 1992, BRAIN RES, V579, P261
DUMAN RS, 1997, ARCH GEN PSYCHIAT, V54, P597
DUMAN RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836
EBLEN F, 1995, J NEUROSCI, V15, P5999
EVERITT BJ, 2005, NAT NEUROSCI, V8, P1481
FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71
FELTEN DL, 1980, NEUROSCI LETT, V16, P275
FENSTERMACHER J, 1988, ANN NY ACAD SCI, V531, P29
FENSTERMACHER JD, 1974, FLUID ENV BRAIN, P201
FERGUSON SSG, 2003, TRENDS NEUROSCI, V26, P119
FERRE S, 1996, EUR J NEUROSCI, V8, P1545
FISHMAN RA, 1992, CEREBROSPINAL FLUID
FLACK B, 1962, J HISTOCHEM CYTOCHEM, V10, P348
FOLLESA P, 1994, EXP NEUROL, V127, P37
FROSSBERG H, 2006, BEHAV BRAIN FUNCT, V2, P40
FUXE K, 1963, ACTA PHYSIOL SCAND, V58, P383
FUXE K, 1964, ACTA PHYSIOL SCAND, V62, P493
FUXE K, 1964, Z ZELLFORSCH, V61, P710
FUXE K, 1965, ACTA PHYSIOL SC S247, V64, P37
FUXE K, 1965, Z ZELLFORSCH, V65, P573
FUXE K, 1966, ACTA PHYSIOL SCAND, V66, P245
FUXE K, 1967, HISTOCHEMISTRY, V11, P161
FUXE K, 1967, J PHARM PHARMACOL, V19, P335
FUXE K, 1967, PSYCHOPHARMACOLOGIA, V11, P439
FUXE K, 1968, HISTOCHEMISTRY, V13, P16
FUXE K, 1970, AMPHETAMINES RELATED, P257
FUXE K, 1970, CONTEMPORARY RESEARC, P275
FUXE K, 1970, INT REV NEUROBIOL, V13, P93
FUXE K, 1970, NEUROLEPTICS, P121
FUXE K, 1970, RES COMMUN CHEM PATH, V1, P627
FUXE K, 1973, J HISTOCHEM CYTOCHEM, V21, P293
FUXE K, 1973, SLEEP PHYSL BIOCH PS, P12
FUXE K, 1974, ADV BIOCHEM PSYCHOPH, V10, P1
FUXE K, 1976, SCHIZOPHRENIA TODAY, P135
FUXE K, 1977, MED BIOL, V55, P148
FUXE K, 1977, NEUROSCI LETT, V6, P339
FUXE K, 1977, SCIENCE, V196, P899
FUXE K, 1978, CLIN OBSTET GYNAECOL, V5, P251
FUXE K, 1979, TRENDS NEUROSCI, V2, P1
FUXE K, 1980, ADV BIOCHEM PSYCHOPH, V22, P37
FUXE K, 1980, EUR J PHARMACOL, V67, P329
FUXE K, 1980, PROGR PSYCHONEUROEND, P47
FUXE K, 1981, ACTA PHYSL SCAND, V113, P567
FUXE K, 1983, J NEURAL TRANSM S18, P165
FUXE K, 1983, NEUROPHARMACOLOGY, V22, P389
FUXE K, 1983, NEUROSCI LETT, V43, P185
FUXE K, 1983, SPECIAL ASPECTS PSYC, P13
FUXE K, 1985, DOPAMINERGIC SYSTEM, P11
FUXE K, 1985, MED RES REV, V5, P441
FUXE K, 1986, PROG BRAIN RES, V66, P341
FUXE K, 1988, ADV EXP MED BIOL, V235, P83
FUXE K, 1988, NEUROSCI LETT, V85, P163
FUXE K, 1988, REGULATORY ROLES OPI, P33
FUXE K, 1991, GALANIN NEW MULTIFUN, P221
FUXE K, 1991, VOLUME TRANSMISSION
FUXE K, 1991, VOLUME TRANSMISSION, P1
FUXE K, 1996, J CHEM NEUROANAT, V11, P13
FUXE K, 2003, NEUROLOGY, V61, PS19
FUXE K, 2003, NEUROSCIENCE, V119, P733
FUXE K, 2005, J NEURAL TRANSM, V112, P65
FUXE K, 2006, J NEURAL TRANSM-SUPP, P71
FUXE K, 2006, NEUROTRANSMIITER ERA, P219
FUXE K, 2007, J NEURAL TRANSM, V114, P49
GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547
GALTER D, 1999, NEUROSCIENCE, V88, P549
GARCIAPEREZ E, 2004, BIOPHYS J 1, V86, P646
GARRIS PA, 1994, J NEUROSCI, V14, P6084
GARTHWAITE J, 1989, EUR J PHARM-MOLEC PH, V172, P413
GEER CP, 1997, J NEURO-ONCOL, V32, P193
GEFFEN LB, 1976, NATURE, V260, P258
GERFEN CR, 1984, NATURE, V311, P461
GERFEN CR, 1993, NIDA RES MONOGRAPH S, V125, P82
GERFEN CR, 2000, TRENDS NEUROSCI S, V23, PS64
GINES S, 2000, P NATL ACAD SCI USA, V97, P8606
GOLDING DW, 1994, BIOESSAYS, V16, P503
GONON FG, 1988, NEUROSCIENCE, V24, P19
GONZALEZ MMC, 2006, SLEEP, V29, P1327
GRACE AA, 1983, NEUROSCIENCE, V10, P333
GRANON S, 2006, ACTA PAEDIATR, V95, P645
GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723
GRAYBIEL AM, 2000, TRENDS NEUROSCI S, V23, PS71
GREITZ D, 1991, NEURORADIOLOGY S, V33, P178
GREITZ D, 1993, ACTA RADIOL S, V386, P1
GREITZ D, 1993, ACTA RADIOL, V34, P321
GREWAL JS, 2001, J BIOL CHEM, V276, P27335
GUILLEMIN R, 1978, SCIENCE, V202, P390
GWINN RP, 2002, NEUROSCIENCE, V114, P403
HACKEL PO, 1999, CURR OPIN CELL BIOL, V11, P184
HAJOS M, 1994, 3 IUPHAR SAT M SER
HAMBERGER B, 1965, J HISTOCHEM CYTOCHEM, V13, P147
HANSRA N, 2004, J NEUROSCI, V24, P4082
HASKINS JT, 1981, J NEUROCYTOL, V10, P729
HAYAISHI O, 1991, FASEB J, V5, P2575
HEDLUND PB, 1992, EUR J PHARMACOL, V224, P203
HEDLUND PB, 1994, BRAIN RES, V634, P163
HEDLUND PB, 1996, ANN NY ACAD SCI, V780, P193
HEIMER L, 2000, BRAIN RES REV, V31, P205
HERKENHAM M, 1987, NEUROSCIENCE, V23, P1
HERY F, 1982, BRAIN RES BULL, V8, P123
HILLION J, 2002, J BIOL CHEM, V277, P18091
HOFFMAN BJ, 1998, FRONT NEUROENDOCRIN, V19, P187
HOISTAD M, 2000, EUR J NEUROSCI, V12, P2505
HOISTAD M, 2002, J NEUROCHEM, V81, P80
HOISTAD M, 2004, THESIS KAROLINSKA I, P82
HOISTAD M, 2005, BRAIN RES, V1041, P167
HOMYKIEWICZ O, 1963, WEIN KLIN WOCHENSCHR, V75, P309
HORVATH TL, 1999, J NEUROSCI, V19, P10417
HORVATH TL, 2003, BIOCHEM PHARMACOL, V65, P1917
HOYER D, 2002, PHARMACOL BIOCHEM BE, V71, P533
HUBBARD SR, 2004, NAT REV MOL CELL BIO, V5, P464
HURD YL, 2006, CNS SPECTRUMS, V11, P855
IADECOLA C, 1998, NAT NEUROSCI, V1, P263
ICHIMURA T, 1991, BRAIN RES, V545, P103
ISHIMATSU M, 1996, J NEUROSCI, V16, P5196
IVANOV IS, 2006, CNS SPECTRUMS, V11, P864
IVERSEN L, 2000, MOL PSYCHIATR, V5, P357
JACKSON IMD, 1980, NEUROBIOLOGY CEREBRO, P625
JACOBS BL, 1992, PHYSIOL REV, V72, P165
JACOBSEN KX, 2006, NEUROSCIENCE, V141, P2007
JACOBSON M, 1993, FDN NEUROSCIENCE
JAN LY, 1982, J PHYSIOL-LONDON, V327, P219
JAN YN, 1983, PROG BRIAN RES, V58, P49
JANSSON A, 1998, NEUROREPORT, V9, P2505
JANSSON A, 1999, NEUROSCIENCE, V89, P473
JANSSON A, 1999, THESIS KAROLINSKA I, P61
JANSSON A, 2000, PROG BRAIN RES, V125, P399
JANSSON A, 2001, J CHEM NEUROANAT, V22, P185
JANSSON A, 2002, NEURONAL ENV BRAIN H, P83
JANSSON A, UNPUB LOCAL MICROINJ
JENTSCH JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201
JONSSON G, 1975, MED BIOL, V53, P25
JOUVET M, 1972, ERGEBN PHYSL, V64, P166
KAMIYA T, 2003, BIOCHEM BIOPH RES CO, V306, P544
KANG HJ, 1995, SCIENCE, V267, P1658
KAPUR S, 2003, PROG NEURO-PSYCHOPH, V27, P1081
KEMPERMANN G, 2003, BIOL PSYCHIAT, V54, P499
KIIANMAA K, 1977, BRAIN RES, V131, P287
KIM JS, 1980, NEUROSCI LETT, V20, P379
KIMELBERG H, 1988, GLIAL CELL RECEPTORS
KISER RS, 1983, BRAIN RES, V288, P187
KITAYAMA IT, 2004, ACTA NEUROPSYCHIATR, V16, P190
KOMENDANTOV AO, 2002, J NEUROPHYSIOL, V87, P1526
KOOB G, 1990, DECADE NEUROPEPTIDES
KOPELL N, 2004, P NATL ACAD SCI USA, V101, P15482
KOTECHA SA, 2002, NEURON, V35, P1111
KRUEGER JM, 1995, INT ARCH ALLERGY IMM, V106, P97
KUHAR MJ, 1985, NIDA RES MONOGR, V62, P1
LARUELLE M, 1996, P NATL ACAD SCI USA, V93, P9235
LARUELLE M, 2003, ANN NY ACAD SCI, V1003, P138
LAUF U, 2002, P NATL ACAD SCI USA, V99, P10446
LEBIHAN D, 1993, NEUROREPORT, V4, P887
LEE FJS, 2002, CELL, V111, P219
LEE FS, 2001, P NATL ACAD SCI USA, V98, P3555
LEE FS, 2002, CYTOKINE GROWTH F R, V13, P11
LESCH KP, 2001, J AFFECT DISORDERS, V62, P57
LEUNG DSY, 2002, INT J DEV NEUROSCI, V20, P63
LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861
LI XM, 1995, BRAIN RES, V679, P157
LICINIO J, 1997, J CLIN INVEST, V100, P2941
LIDBRINK P, 1973, J PHARM PHARMACOL, V25, P84
LINDVALL O, 1974, ACTA PHYSIOL SCAND, V412, P1
LIPPOLDT A, 2000, BRAIN RES, V854, P197
LIPPOLDT A, 2000, NEUROREPORT, V11, P1427
LIU F, 2000, NATURE, V403, P274
LIU HT, 1994, P NATL ACAD SCI USA, V91, P1009
LIU XY, 2006, NEURON, V52, P897
LOFSTROM A, 1976, J HISTOCHEM CYTOCHEM, V24, P415
LOFSTROM A, 1976, J HISTOCHEM CYTOCHEM, V24, P430
LOWES VL, 2002, NEUROSIGNALS, V11, P5
LUTTRELL LM, 1997, J BIOL CHEM, V272, P4637
LUTTRELL LM, 1999, CURR OPIN CELL BIOL, V11, P177
LUTTRELL LM, 2002, CAN J PHYSIOL PHARM, V80, P375
MACLEOD RM, 1974, ENDOCRINOLOGY, V94, P1077
MACMILLAN SJA, 1998, BRAIN RES, V794, P127
MAEDA T, 1972, BRAIN RES, V36, P19
MALLEI A, 2002, MOL PHARMACOL, V61, P1017
MALMFORS T, 1965, ACTA PHYSIOL SCAND S, V248, P1
MANJI HK, 2001, NAT MED, V7, P541
MANJI HK, 2003, SCI STKE, PE49
MANSOUR A, 1986, BRAIN RES, V399, P69
MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308
MARAGNOLI ME, 2004, BIOL PSYCHIAT, V55, P1095
MARCELLINO D, 2007, BRAIN RES, V1143, P208
MARINISSEN MJ, 2001, TRENDS PHARMACOL SCI, V22, P368
MARTIN DL, 1992, GLIA, V5, P81
MARTIN JH, 1985, PRINCIPLES NEURAL SC, P636
MARTINCORA FJ, 2005, EUR J NEUROSCI, V22, P3195
MATTEOLI M, 1988, P NATL ACAD SCI USA, V85, P7366
MATTSON MP, 2004, TRENDS NEUROSCI, V27, P589
MAYERI E, 1985, J NEUROSCI, V5, P2060
MEYERLINDENBERG A, 2002, NAT NEUROSCI, V5, P267
MIYAN JA, 2003, CAN J PHYSIOL PHARM, V81, P317
MOBLEY P, 1985, P NATL ACAD SCI USA, V82, P945
MOLLGARD K, 1975, ADV NEUROL, V12, P79
MONTAGUE PR, 1996, J NEUROSCI, V16, P1936
MORRIS G, 2004, NEURON, V43, P133
MORRIS M, 1975, NEUROENDOCRINOLOGY, V18, P131
MURASE S, 1993, J NEURAL TRANSM-GEN, V91, P13
MURPHY BL, 2000, ENVIRON FORENSICS, V1, P155
MURPHY S, 1987, NEUROSCIENCE, V22, P381
MURPHY S, 1993, TRENDS NEUROSCI, V16, P323
NAGY JI, 2004, BRAIN RES REV, V47, P191
NEDERGAARD M, 1994, SCIENCE, V263, P1768
NEMEROFF CB, 1998, BIOL PSYCHIAT, V44, P517
NESTLER EJ, 2002, NEURON, V34, P13
NEWMANTANCREDI A, 1997, EUR J PHARMACOL, V319, P379
NIBUYA M, 1995, J NEUROSCI, V15, P7539
NICHOLSON C, 1979, NEUROSCIENCES 4 STUD
NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225
NICHOLSON C, 1998, TRENDS NEUROSCI, V21, P207
NICHOLSON C, 1999, TRENDS NEUROSCI, V22, P143
NICHOLSON C, 2001, REP PROG PHYS, V64, P815
NIEUWENHUYS R, 1985, CHEMOARCHITECTURE BR
NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227
NYGREN LG, 1977, BRAIN RES, V132, P85
OADES RD, 2005, DEVELOPMENTAL SCI, V8, P122
OGREN SO, 1979, J NEURAL TRANSM, V46, P85
OLSON L, 1971, BRAIN RES, V28, P165
OLSON L, 1972, BRAIN RES, V43, P289
OLSON L, 1972, BRAIN RES, V44, P283
ORMOND J, 2004, NEURON, V44, P715
OUIMET CC, 1984, J NEUROSCI, V4, P111
PASQUINI F, 1992, J COMP NEUROL, V326, P229
PATAPOUTIN A, 2001, CURR OPIN NEUROBIOL, V11, P272
PATHAK A, 2003, BRIT J NEUROSURG, V17, P306
PAUTPAGANO L, 1993, NEUROENDOCRINOLOGY, V58, P682
PEREDA AE, 1996, J NEUROSCI, V16, P983
PEREDA AE, 1998, P NATL ACAD SCI USA, V95, P13272
PEROUTKA SJ, 1979, MOL PHARMACOL, V16, P687
PEROUTKA SJ, 1980, J PHARMACOL EXP THER, V215, P582
POST RM, 1982, LIFE SCI, V31, P1
PROESCHOLDT MG, 2000, NEUROSCIENCE, V95, P577
QUARTA D, 2007, NEUROPSYCHOPHARMACOL, V32, P35
RAJAGOPAL R, 2004, J NEUROSCI, V24, P6650
RAJKOWSKA G, 1999, BIOL PSYCHIAT, V45, P1085
RAUCH BH, 2004, CIRC RES, V94, P340
RENNELS ML, 1985, BRAIN RES, V326, P47
RENNELS ML, 1990, ADV NEUROL, V52, P431
RIAD M, 2000, J COMP NEUROL, V417, P181
RICE ME, 2000, VOLUME TRANSMISSIO R, V125, P277
RIDET JL, 1992, BRAIN RES, V598, P233
RIVERA A, 2002, J NEUROCHEM, V80, P219
RIVERA A, 2006, NEUROSCIENCE, V137, P1447
ROBINSON TE, 1993, BRAIN RES REV, V18, P247
ROCHEVILLE M, 2000, SCIENCE, V288, P154
RORIG B, 1996, EUR J NEUROSCI, V8, P1685
ROUTTENBERG A, 1968, SCIENCE, V161, P272
RUSAKOV DA, 1998, TRENDS NEUROSCI, V21, P469
RUSAKOV DA, 1999, TRENDS NEUROSCI, V22, P382
SAARELAINEN T, 2003, J NEUROSCI, V23, P349
SALAMONE JD, 1997, NEUROSCI BIOBEHAV R, V21, P341
SANTARELLI L, 2003, SCIENCE, V301, P805
SCHAIBLE HG, 1992, EUR J NEUROSCI, V4, P750
SCHLOSS P, 2004, PHARMACOL THERAPEUT, V102, P47
SCHMITT FO, 1984, NEUROSCIENCE, V13, P991
SCHMITZ D, 2001, NEURON, V31, P831
SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397
SCHULTZ W, 2002, NEURON, V36, P241
SCHWARTZ JC, 1998, BRAIN RES REV, V26, P236
SEEMAN P, 1975, P NATL ACAD SCI USA, V72, P4376
SEGAL MB, 2000, CELL MOL NEUROBIOL, V20, P183
SESACK SR, 1994, J NEUROSCI, V14, P88
SHAH BH, 2004, TRENDS NEUROSCI, V27, P48
SHEPHERD G, 1991, FDN NEURON DOCTRINE
SHEPHERD G, 1994, NEUROBIOLOGY
SHERRINGTON C, 1947, FG INTEGRATIVE ACTIO
SHIPLEY MT, 1996, J COMP NEUROL, V365, P56
SHIRAYAMA Y, 2002, J NEUROSCI, V22, P3251
SILVER R, 1996, NATURE, V382, P810
SKINNER DC, 1999, ENDOCRINOLOGY, V140, P4399
SKIRBOLL LR, 1979, SCIENCE, V206, P80
SKOLNICK P, 1999, EUR J PHARMACOL, V375, P31
SNYDER SH, 1991, TRENDS PHARMACOL SCI, V12, P125
SOHL G, 2005, NAT REV NEUROSCI, V6, P191
SONTHEIMER H, 1988, GLIA, V1, P328
SOSSIN WS, 1989, NEURON, V2, P1407
STEINBUSCH HWM, 1978, NEUROSCIENCE, V3, P811
STEINBUSCH HWM, 1981, ADV EXP MED BIOL, V133, P7
STEINBUSCH HWM, 1981, J PHYSIOL-PARIS, V77, P157
STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557
STEZHKA VV, 1995, EXP BRAIN RES, V105, P383
STONE EA, 1989, BRAIN RES REV, V14, P297
STROMBERG I, 2000, PROG BRAIN RES, V125, P309
SVENSSON TH, 2000, BRAIN RES REV, V31, P320
SYKOVA E, 1998, EXP GERONTOL, V33, P837
SYKOVA E, 2004, NEUROCHEM INT, V45, P453
TAKASE LF, 2004, BEHAV BRAIN RES, V153, P233
TAMAS G, 2000, NAT NEUROSCI, V3, P366
TAYLOR C, 2005, CELL SIGNAL, V17, P549
TENNYSON VM, 1972, BRAIN RES, V46, P251
THURESONKLEIN AK, 1990, INT REV CYTOL, V121, P67
TORVINEN M, 2005, MOL PHARMACOL, V67, P400
TRAVAGLI RA, 1995, J NEUROPHYSIOL, V74, P518
TURNER CA, 2006, BIOL PSYCHIAT, V59, P1128
UMBRIACO D, 1994, J COMP NEUROL, V348, P351
UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107
UNGERSTEDT U, 1969, BRAIN RES, V14, P461
UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND S, V367, P1
UNGLESS MA, 2004, TRENDS NEUROSCI, V27, P702
URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070
USHER M, 1999, SCIENCE, V283, P549
VANDECASTEELE M, 2005, J NEUROSCI, V25, P291
VANHARREVELD A, 1972, STRUCTURE FUNCTION N, P447
VINCENT B, 1996, J NEUROSCI, V16, P5049
VIZI E, 1984, NONSYNAPTIC INTERACT
VORISEK I, 1997, J NEUROPHYSIOL, V78, P912
WANG R, 2002, FASEB J, V16, P1792
WANG RY, 1982, J NEUROSCI, V2, P11
WANG Y, 1996, LIFE SCI, V59, P1783
WESTERINK BHC, 2001, J NEUROSCI METH, V109, P53
WIESEL FA, 1978, BRAIN RES, V148, P399
WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P5667
YABLONSKIY DA, 2000, P NATL ACAD SCI USA, V97, P7603
YUNG KKL, 1995, NEUROSCIENCE, V65, P709
ZHANG ET, 1992, ACTA NEUROPATHOL, V83, P233
ZHU PC, 1986, NEUROSCIENCE, V19, P43
ZIGMOND MJ, 2000, PROG BRAIN RES, V125, P317
ZOLI M, 1989, ACTA PHYSIOL SCAND, V135, P201
ZOLI M, 1996, PROG NEUROBIOL, V49, P363